Castle Biosciences (CSTL) Times Interest Earned (2018 - 2026)
Castle Biosciences' (CSTL) quarterly Times Interest Earned came in at -$137.37 in Q1 2026, up 91.64% year-on-year from -$71.68 in Q1 2025, and up 13.85% quarter-over-quarter from -$159.46 in Q4 2025.
Castle Biosciences (CSTL) Times Interest Earned (2018 - 2026) Analysis & Trends
Castle Biosciences has disclosed Times Interest Earned across 9 years of filings, most recently posting -$137.37 for Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$137.37, up 91.64% year-over-year; the trailing twelve-month figure through Mar 2026 was -$163.99 (down 589.86% YoY), and the FY2025 annual result was -$497.79, down 3412.86% from the prior year.
- Times Interest Earned came in at -$137.37 for Q1 2026 at Castle Biosciences, up from -$159.46 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $44.02 in Q4 2024 to a low of -$8172.0 in Q1 2022.
- The 5-year median for Times Interest Earned is -$992.75 (2022), against an average of -$2578.7.
- Across the five-year window, Times Interest Earned soared 101.56% in 2024 and sank 1221.94% in 2025, its largest moves.
- Castle Biosciences' Times Interest Earned stood at -$5708.0 in 2022, then jumped by 50.44% to -$2829.0 in 2023, then jumped by 101.56% to $44.02 in 2024, then sank by 462.23% to -$159.46 in 2025, then increased by 13.85% to -$137.37 in 2026.
- The last three Times Interest Earned figures came in at -$137.37 (Q1 2026), -$159.46 (Q4 2025), and -$283.5 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -0.98 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 5.26 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 21.33 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 46.84 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 15.96 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -104.84 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 2.68 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 8.71 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 14.05 |
| 10 | Castle Biosciences | 629.76 Mn | 368.04 Mn | 63.15 Mn | -137.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -137.37 |
| Dec 31, 2025 | -159.46 |
| Sep 30, 2025 | -283.50 |
| Jun 30, 2025 | -202.43 |
| Mar 31, 2025 | -1,642.82 |
| Dec 31, 2024 | 44.02 |
| Sep 30, 2024 | 25.27 |
| Jun 30, 2024 | 18.56 |
| Mar 31, 2024 | -455.92 |
| Dec 31, 2023 | -2,829.00 |
| Sep 30, 2023 | -4,820.00 |
| Jun 30, 2023 | -7,052.33 |
| Mar 31, 2023 | -7,880.50 |
| Dec 31, 2022 | -5,708.00 |
| Sep 30, 2022 | -3,589.33 |
| Jun 30, 2022 | -992.75 |
| Mar 31, 2022 | -8,172.00 |
| Dec 31, 2021 | -15,171.00 |
| Dec 31, 2020 | -7.68 |
| Sep 30, 2020 | -5.53 |